Micro and Nano Technologies : Nanomedicines for breast cancer theranostics.

Contributor(s):

Material type: Text

TextSeries: Nanotechnology in the life sciencesPublisher: United Kingdom : Elsevier , [2020Description: 1 online resource : illustrations (chiefly color)Content type:

text

Media type:

computer

Carrier type:

online resource

ISBN:

9780128200162 :

Subject(s):

Genre/Form:

Electronic books.

Additional physical formats: No titleDDC classification:

616.99/406 23

LOC classification:

RC270.8 .M36 2021

Online resources:

Contents:

Preface -- Nanotheranostics -- Multifunctional Nanoparticles for Targeting Cancer Nanotheranostics -- Nano-Oncology -- Cancer-Targeted Nanotheranostics -- Nanotheranostics -- Cancer Nano-Immunotherapy -- Recent Advances in Lipid-Based Nanoformulations for Breast Cancer Theranostics -- Nanoparticle for Photoresponsive Minimal-Invasive Cancer Therapy -- Biologically Synthesized Plant-Derived Nanomedicines and their In-Vitro In-Vivo Toxicity Studies in Various Cancer Therapeutics -- Nanoerythrosome -- Role of Artificial Intelligence in Cancer Nanotheranostics -- Limitations of Current Cancer Nanotheranositcs -- Safety of nanobiomaterials for Cancer Nanotheranostics -- Index.

Summary: Cancer Nanotheranostics, Volume 2 continues the discussion of the important work being done in this field of cancer nanotechnology. The contents of these two volumes are explained in detail as follows. In the first volume of Cancer Nanotheranostics, we discussed the role of different nanomaterials for cancer therapy including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials, and nano-antibodies. This important second volume discusses nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nanoerythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, safety of nanobiomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics. Volume 2 is a vital continuation of this two-volume set. Together, these two volumes create a comprehensive and unique examination of this important area of research.

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Date due	Barcode
Books	Chinhoyi University of Technology Libraries	Chinhoyi University of Technology Libraries	RC 270 NAN (Browse shelf(Opens below))	C.047168	Available		BK0092350

Browsing Chinhoyi University of Technology Libraries shelves Close shelf browser (Hides shelf browser)

Previous								Next
Previous	RC 261 CAN Cancer and cancer care /	RC 266 NUR Nursing in haematological oncology /	RC 267 CAN Cancer clinical trials : proactive strategies /	RC 270 NAN Micro and Nano Technologies : Nanomedicines for breast cancer theranostics.	RC 270.3 ERL Diagnostic transmission electron microscopy of tumors : with clinicopathological, immunohistochemical and cytogenetic correlations /	RC 270.8 KIR Current cancer therapeutics /	RC271.C5 DRU Drug repurposing in cancer therapy : approaches and applications /	Next

Includes bibliographical references.

Available to OhioLINK libraries.

Cancer Nanotheranostics, Volume 2 continues the discussion of the important work being done in this field of cancer nanotechnology. The contents of these two volumes are explained in detail as follows. In the first volume of Cancer Nanotheranostics, we discussed the role of different nanomaterials for cancer therapy including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials, and nano-antibodies. This important second volume discusses nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nanoerythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, safety of nanobiomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics. Volume 2 is a vital continuation of this two-volume set. Together, these two volumes create a comprehensive and unique examination of this important area of research.

There are no comments on this title.

to post a comment.